National Glaucoma Society: Topics

Case of the Month STAGING

Topics: What's Worse Than a Migraine?; Uveitic Glaucoma; Episodic Damage to the RNFL; The Importance of Risk Factors for Younger Patients; Glaucoma and Retinal Pathologies; Bilateral NAION; Neuroretinal Rim Defects; Optic Neuritis; Iridotomy; Angle Closure Due to Topamax; Iridotomy Part II: Was It Successful?; Uveitis and Elevated IOP; Is This Glaucoma?; Anomalous Optic Nerve; Asymmetry; Detecting Visual Field Progression in Glaucoma; Unusual Side Effect of Topical Glaucoma Medication; Angle Recession; IOL Iris Defect; Glaucoma Damage in a Younger Patient; OCT and Ocular Lesions; Monitoring Conjuctival Lesions; Visual Fields vs. Optic Nerve Imaging; Sjogren's Syndrome; Duane's Retraction Syndrome

Webinars STAGING

Topics: Cirrus HD-OCT Technology; Why Measure the Macula in Glaucoma; NGS to Offer Webinars; SAMPLE NGS WEBINAR; Clinical Pearls from The OHTS Study; Fluctuations in IOP; Using a Smart Phone or Tablet for Webinars; Optic Nerve Evaluation; Insights into the Use of Technology: Glaucoma Change Over Time; The Use of OCTs in Glaucoma; Will the Real IOP Please Stand Up; Using Chat During a Webinar; Instructions for Joining an NGS Webinar; Ganglion Cell Analysis; Disc Hemorrhage; Peripapillary Atrophy; CE Approval for Webinars will be Obtained from Individual States; Patient Compliance; Setting up Webinar Audio on Smart Phones; Sleep Apnea Test
Discussions: Re: Using a Smart Phone or Tablet for Webinars; sign up for Nov 18 webinar; Re: Using a Smart Phone or Tablet for Webinars; No, the chat window is part of the WebEx video conferencing. You need to enable it once you are on the webinar by clicking on the grey speech bubble in
read more; Re: Using a Smart Phone or Tablet for Webinars; I cant seem to get the chat window open? Is this the same?

Industry News STAGING

Topics: New FDA Approval for Lumigan; Alcon's Travatan Z Solution Receives FDA Approval; Alcon's Travatan Z and Systane Use Different Preservatives; Pfizer Sponsors New "All Eyes on Glaucoma" Website; CLIA Waivers; Bausch + Lomb New Glaucoma Drug; DREAM Study; Vivid Vision Perimetry
Discussions: Re: Alcon's Travatan Z Solution Receives FDA Approval; Dr. Ghosh, If you click on the Alcon logo on the lower right side of this website, it will bring you to Alcon's Travatan website where there is complete product information
read more; Re: Alcon's Travatan Z Solution Receives FDA Approval; I would like to receive some full text about the new approved drug Travatan Z

Clinical Guidelines STAGING

Topics: CCT: Is is time to say YES?; The Role of CCT in Glaucoma Patients; More CCT; The Paradox of IOP; Should We Treat All Ocular Hypertensives?; Beta Blockers in Glaucoma Management; Re-Defining Ocular Hypertension; Implications of Macro-Disc Asymmetry in Glaucoma Suspects; Nine-Year Changes in Intraocular Pressure: The Barbadoes Eye Studies
Discussions: Re: The Paradox of IOP; At a recent education event one of our attendees asked me to find out the incidence of ocular hypertension in the general population. I could not identify a study noting
read more

Pharmacology Update STAGING

Topics: Extravan: Alcon Pharmaceuticals; Mechanism of IOP Reduction with Travoprost
Discussions: Re: Extravan: Alcon Pharmaceuticals; Extravan has not yet received FDA approval in the U.S. However, Alcon's Travatan/Timolol fixed combination is approved as DuoTrav in Europe, Australia and Canada. It is approved for dosing in
read more; Re: Extravan: Alcon Pharmaceuticals; Dr. Fisher - I have not used any combo drugs at this time. I have asked Paul Smith from Alcon to post an answer. Let's see what Alcon reports. Thanks; Re: Extravan: Alcon Pharmaceuticals; Extravan is QD dosing. Timolol is QAM and Travatan is QHS. When is Extravan used?

In Your Office STAGING

Topics: Glaucoma Flowsheet; Tonometer Calibration; Pachymetry Coding; BCBS Coverage of SCODI Services; Expanded Coverage of Glaucoma Screening Services; Coding Update: 92135 Deleted and Replaced; ABO Certification Review Materials; Small Fee Reduction in CMS Payments in 2015; Moist Heat Compresses; Information about Omega-3s
Discussions: Re: Moist Heat Compresses; You also discussed information and possible group pricing about a gland expresser and said you would provide information regarding that instrument. Please post that information. Thank you.; Re: ABO Certification Review Materials; Could you please send the glaucoma review information and uveitis labs worksheets to lmillod@ptd.net.; Re: ABO Certification Review Materials; I also attended the SECO course, could you please email the ABO certification review material to davidfierceod@yahoo.com. Thanks!

Glaucoma Watch STAGING

Topics: Interesting Glaucoma Cases; From Ocular Hypertension to Glaucoma: How to Predict Conversion; Neckties and IOP: The Controversy Continues; Introduction to the National Glaucoma Society; Case Presentation: Optic Nerve Imaging; NGS Residency Award and Lecture; Optic Nerve Head Measurements with the HRT III; Case Presentation: Laser Imaging Detects Early ON Damage; Is the Optic Disc "Sinking" or "Cupping" in Glaucoma?; Interview with Dr. Barry Barresi; Glaucoma Continuum; Undiagnosed Open Angle Glaucoma: The Thessaloniki Eye Study; The Prevalence of Open-angle Glaucoma Among Blacks and Whites 73 Years and Older; Altered Nitric Oxide System in Patients with Open-Angle Glaucoma; Oxidative Stress in Glaucoma: A Burden of Evidence; Gonioscopy Videos; Glaucoma Risk and the Consumption of Fruits and Vegetables in Older Women; Programs to Optimize Adherence in Glaucoma; Corneal Hysteresis; Visual Field Interpretation; Study Questions link between Glaucoma and Alzheimer's Disease; Checking Color Vision; IOP Asymmetry as Glaucoma Risk Factor; Glaucoma Risk Calculators; Dr. David Calkins Discusses Catalyst for A Cure; Smart Phone Biosensor; Handheld OCT; Sustained Release IOP Therapies; Introduction to Corneal Hysteresis; FDT Perimetry; Visual Fields Overview; National Glaucoma Symposium 2017; Gonioscopy Slides from 2017 National Glaucoma Symposium; Measuring Corneal Hysteresis; XEN Glaucoma Implant Video; XEN Animation #2; Glaucoma Quality of Life; Diabetic Retinopathy; Advances in Glaucoma Therapy; Laser Therapy; SLT as First Line Therapy; Test; Webinar Instructions; Dunbar OCT; More about the OCT; Testing This Database 2
Discussions: Re: From Ocular Hypertension to Glaucoma: How to Predict Conversion; Very interesting article; Re: National Glaucoma Symposium 2011; Another successful conference! See you next year July 28-30, 2012.; Re: Undiagnosed Open Angle Glaucoma: The Thessaloniki Eye Study; In reading the details found within the journal article highlighted above, it is evident that significant efforts must be made to educate the population better as to the risks of
read more

Your Registrations

You have no registrations currently in your cart.

News

NGS History

The National Glaucoma Society was started in 2004 to provide high-quality glaucoma education to optometrists around the country.

NGS Policy on CE

The National Glaucoma Symposium is a continuing education event designed for scientific and educational purposes only. The National Glaucoma Society is responsible for all decisions regarding the identification of education needs and objectives as well as the selection and presentation of program content, educational methods and evaluation of the program.

Michigan CE Regulations

All attendees must reply to random questions by the host during the webinar to confirm their continued presence during the lecture. Participants must remain on the webinar for at least 55 minutes in order to receive CE credit in Michigan.

WEBINARS SUBMITTED TO MINNESOTA AND VERMONT

The NGS continues to monitor changes in State Regulations that allow continuing education through live webinar formats. As a result, we have applied to two more states for approval of the NGS live webinars. In Minnesota, new regulations went into effect July 11, 2018 which acknowledge interactive courses can be live or remote via a webinar, teleconferencing or videoconferencing; the NGS has applied to the Minnesota Board for approval of the October webinars. Vermont regulations permit continuing education programs conducted on-line; the NGS has applied to the Vermont Board for approval of the October - December webinars.

Webinars approved in Connecticut

The NGS live webinars are now approved as online CE in CT.

EVENING WEBINARS

Starting in January 2018, the NGS webinars will take place in the evening from 8-9 pm Eastern time.

EVENING WEBINARS IN 2018

The evening webinars seem to be more convenient than the morning webinars for optometrists' work and family schedules, since more optometrists attend the NGS evening webinars than the morning ones. To accommodate this preference, the NGS live webinars in January - May 2018 will all be evening webinars from 8-9 p.m. Eastern time. We will re-evaluate this change prior to the fall 2018 webinars.

WEBINARS ON NOV 15 AND DEC 6 SWITCHING PLACES

Due to a scheduling conflict, Dr. Schmidt and Dr. Thimons are switching places on the fall webinar schedule. Dr. Thimons will now present the evening webinar on November 15 and Dr. Schmidt will present the morning webinar on December 6. Original lecture topics remain the same.

Join Our Email List

National Glaucoma Society